|
1
|
Lai HM, Aronow WS, Mercando AD, Kalen P,
Desai HD, Gandhi K, Sharma M, Amin H and Lai TM: The impact of
statin therapy on long-term cardiovascular outcomes in an
outpatient cardiology practice. Med Sci Monit. 17:CR683–CR686.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xiao X, Chang G, Liu J, Sun G, Liu L, Qin
S and Zhang D: Simvastatin ameliorates ventricular remodeling via
the TGF-β1 signaling pathway in rats following myocardial
infarction. Mol Med Rep. 13:5093–5101. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Reichert K, do Carmo Pereira HR, Torina
Galluce A, de Carvalho Diógenes D, Sposito Carvalho A, de Souza
Vilarinho KA, da Mota Silveira-Filho L, de Oliveira Martins PP and
Petrucci O: Atorvastatin improves ventricular remodeling after
myocardial infarction by interfering with collagen metabolism. PLoS
One. 11:e01668452016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Martin JH, Connelly KA, Boyle A, Kompa A,
Zhang Y, Kelly D, Gilbert RE and Krum H: Effect of atorvastatin on
cardiac remodelling and mortality in rats following hyperglycemia
and myocardial infarction. Int J Cardiol. 143:353–360. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tang XL, Sanganalmath SK, Sato H, Bi Q,
Hunt G, Vincent RJ, Peng Y, Shirk G, Dawn B and Bolli R:
Atorvastatin therapy during the peri-infarct period attenuates left
ventricular dysfunction and remodeling after myocardial infarction.
PLoS One. 6:e253202011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mihaylova B, Emberson J, Blackwell L,
Keech A, Simes J, Barnes EH, Voysey M, Gray A, Collins R and
Baigent C: Cholesterol Treatment Trialists' (CTT) Collaborators:
The effects of lowering LDL cholesterol with statin therapy in
people at low risk of vascular disease: Meta-analysis of individual
data from 27 randomised trials. Lancet. 380:581–590. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Song T, Liu J, Tao X and Deng JG:
Protection effect of atorvastatin in cerebral ischemia-reperfusion
injury rats by blocking the mitochondrial permeability transition
pore. Genet Mol Res. 13:10632–10642. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Whitehead NP, Kim MJ, Bible KL, Adams ME
and Froehner SC: A new therapeutic effect of simvastatin revealed
by functional improvement in muscular dystrophy. Proc Natl Acad Sci
USA. 112:12864–12869. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee J, Hong EM, Jang JA, Park SW, Koh DH,
Choi MH, Jang HJ and Kae SH: Simvastatin induces apoptosis and
suppresses insulin-like growth factor 1 receptor in bile duct
cancer cells. Gut Liver. 10:310–317. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Neukamm A, Høiseth AD, Einvik G, Lehmann
S, Hagve TA, Søyseth V and Omland T: Rosuvastatin treatment in
stable chronic obstructive pulmonary disease (RODEO): A randomized
controlled trial. J Intern Med. 278:59–67. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang M, Li Z, Zhang X, Xie X, Zhang Y,
Wang X and Hou Y: Rosuvastatin attenuates atrial structural
remodelling in rats with myocardial infarction through the
inhibition of the p38 MAPK signalling pathway. Heart Lung Circ.
24:386–394. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Waldman LK, Nosan D, Villarreal F and
Covell JW: Relation between transmural deformation and local
myofiber direction in canine left ventricle. Circ Res. 63:550–562.
1988. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li L, Craft M, Hsu HH, Zhang M, Klas B,
Danford DA and Kutty S: Left ventricular rotational and twist
mechanics in the human fetal heart. J Am Soc Echocardiogr.
30(773–780): e12017.
|
|
14
|
Amundsen BH, Helle-Valle T, Edvardsen T,
Torp H, Crosby J, Lyseggen E, Støylen A, Ihlen H, Lima JA, Smiseth
OA, et al: Noninvasive myocardial strain measurement by speckle
tracking echocardiography: Validation against sonomicrometry and
tagged magnetic resonance imaging. J Am Coll Cardiol. 47:789–793.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Aurich M, Keller M, Greiner S, Steen H,
Siepen Aus dem F, Riffel J, Katus HA, Buss SJ and Mereles D: Left
ventricular mechanics assessed by two-dimensional echocardiography
and cardiac magnetic resonance imaging: Comparison of
high-resolution speckle tracking and feature tracking. Eur Heart J
Cardiovasc Imaging. 17:1370–1378. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sirtori CR: The pharmacology of statins.
Pharmacol Res. 88:3–11. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kinlay S, Schwartz GG, Olsson AG, Rifai N,
Leslie SJ, Sasiela WJ, Szarek M, Libby P and Ganz P: Myocardial
ischemia reduction with aggressive cholesterol lowering study
investigators: High-dose atorvastatin enhances the decline in
inflammatory markers in patients with acute coronary syndromes in
the MIRACL study. Circulation. 108:1560–1566. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mandal P, Chalmers JD, Graham C, Harley C,
Sidhu MK, Doherty C, Govan JW, Sethi T, Davidson DJ, Rossi AG, et
al: Atorvastatin as a stable treatment in bronchiectasis: A
randomised controlled trial. Lancet Respir Med. 2:455–463. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nazli Y, Colak N, Alpay MF, Uysal S,
Uzunlar AK and Cakir O: Neuroprotective effect of atorvastatin in
spinal cord ischemia-reperfusion injury. Clinics (Sao Paulo).
70:52–60. 2015. View Article : Google Scholar : PubMed/NCBI
|
